Test Price
3,200 AED✅ Home Collection Available
NGS Albinism Test in UAE | 3,200 AED | DHA Approved
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS pipeline, every variant confirmed by Sanger sequencing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily from 8 AM to 11 PM, Dubai).
Clinical Guidance: Post‑test telephonic result interpretation with a licensed genetic counsellor within 48 hours of report release.
Insurance Support: Direct billing verification via WhatsApp at +971 54 548 8731 before sample collection.
Test Overview & Methodology
The NGS Albinism Test uses high‑throughput next‑generation sequencing of 19+ albinism‑associated genes, followed by Sanger confirmation of all pathogenic variants, delivering the most comprehensive diagnostic yield in the UAE.
| Feature | Our NGS Albinism Test | Closest Alternative (Single‑Gene Sequencing) |
|---|---|---|
| Methodology | NGS panel + Sanger confirmation (100% coverage of OCA1–OCA8, Hermansky‑Pudlak, etc.) | Sanger sequencing of one or two genes (e.g., TYR only) |
| Diagnostic Yield | ≥99.9% analytical sensitivity & specificity | Limited to targeted mutations; miss rare/novel variants |
| Turnaround Time | 45 working days (expedited reporting available) | Often 60‑90 working days, multiple referral steps |
Physician Insight & Safety Protocols
“Albinism is not only a visual challenge but a multisystem condition that requires meticulous genetic characterisation. This NGS panel detects all clinically relevant subtypes, enabling personalised ophthalmologic and dermatologic surveillance plans from infancy. I always recommend combining the molecular result with a complete physical and family history – a normal result does not exclude rare syndromic forms, so clinical judgment remains paramount.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠️ Important: Do not discontinue or alter any prescribed medication (including photosensitising drugs, immunosuppressants, or topical treatments) without direct consultation with your treating physician. The test result must be correlated with your clinical status before any therapeutic change.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Recent blood transfusion (< 4 weeks), active life‑threatening infection, or inability to provide informed consent (requires legal guardian as per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Red Flags – seek immediate medical attention if: sudden vision loss, severe headache with photophobia, unexplained bleeding/bruising, or signs of skin malignancy (rapidly changing mole, non‑healing ulcer) before receiving test results.
Patient FAQ & Clinical Guidance
1. What exactly does the NGS Albinism Test look for?
The test simultaneously sequences all coding regions of 19 proven albinism genes plus adjacent intronic boundaries, identifying pathogenic variants linked to oculocutaneous and syndromic albinism with >99.9% sensitivity.
2. How should I prepare for the blood draw?
Fasting is not required; however, you must complete the Whole Exome Sequencing Consent Form (Form 37) and present valid Emirates ID and insurance card during home collection for verification.
3. I already have an albinism diagnosis; why should I do this test?
Precise molecular subtyping guides targeted surveillance (e.g., haematological checks for Hermansky‑Pudlak syndrome, pulmonary function monitoring) and informs family planning with accurate recurrence risk counselling not possible by clinical exam alone.
UAE Regulatory & Data Privacy Adherence
Data Protection: Complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Medical Liability: Patient consent and safety governed by Federal Decree-Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | NGS Albinism Test (19‑gene panel + Sanger confirmation) |
| Price (AED) | 3,200 AED |
| Turnaround Time | 45 working days (expedited reporting available) |
| Sample Type / Matrix | Peripheral Whole Blood (3–5 mL in EDTA tube) |
| Methodology Used | Next‑Generation Sequencing (NGS) + Sanger confirmation |
| ICD-10-CM Code | E70.31 (Albinism, unspecified) |
| LOINC Code | 20865-3 (Albinism genetic test) |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians